Literature DB >> 2526038

Plasma levels of atrial natriuretic peptide in patients with liver cirrhosis and its relation to ascites and renal function.

H Fukui1, T Tsujii, M Matsumura, S Okamoto, T Morita, M Koizumi, M Morimura, H Kojima, Y Hokaze, M Fujimoto.   

Abstract

Plasma immunoreactive alpha-human atrial natriuretic polypeptide (Ir-alpha-hANP) was measured by radioimmunoassay in 21 cirrhotics and 10 normal subjects. Average of Ir-alpha-hANP level in cirrhotics was significantly higher than in normal subjects (125.8 +/- 79.6 versus 28.7 +/- 12.2 pg/ml, P less than 0.001). In cirrhotics without ascites, Ir-alpha-hANP levels were positively correlated with creatinine clearance (Ccr) and urinary sodium excretion, suggesting that alpha-hANP was closely related to renal circulation and sodium homeostasis. On the contrary, in cirrhotics with ascites Ir-alpha-hANP levels were negatively correlated with Ccr. Urinary sodium excretion in cirrhotics with ascites and Ccr more than 50 ml/min was positively correlated with Ir-alpha-hANP levels. However, cirrhotics with ascites and Ccr less than 50 ml/min excreted little sodium in spite of high Ir-alpha-hANP levels. On the basis of the Ir-alpha-hANP before and after treatment of ascites, cirrhotics with ascites were subdivided into 2 groups. In group I Ir-alpha-hANP decreased from high values and in group II it was further elevated from slightly high values by treatment. The difference in renal function and plasma volume may account for the difference in Ir-alpha-hANP changes in the 2 groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526038     DOI: 10.1007/bf02774189

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  20 in total

1.  Atrial natriuretic factor--a new hormone affecting kidney function.

Authors:  H Sonnenberg
Journal:  Klin Wochenschr       Date:  1985-09-16

Review 2.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

Authors:  J H Laragh
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

3.  The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties.

Authors:  T G Flynn; M L de Bold; A J de Bold
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

4.  Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.

Authors:  T Maack; D N Marion; M J Camargo; H D Kleinert; J H Laragh; E D Vaughan; S A Atlas
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

5.  Physiology: cardiac peptides and the control of sodium excretion.

Authors:  G A Sagnella; G A MacGregor
Journal:  Nature       Date:  1984 Jun 21-27       Impact factor: 49.962

6.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

7.  Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria.

Authors:  M G Currie; D M Geller; B R Cole; J G Boylan; W YuSheng; S W Holmberg; P Needleman
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

8.  Atrial natriuretic factor in human blood.

Authors:  T Yamaji; M Ishibashi; F Takaku
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects.

Authors:  H R Brunner; L Baer; J E Sealey; J G Ledingham; J H Laragh
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

10.  Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver.

Authors:  R M Arendt; A L Gerbes; D Ritter; E Stangl; P Bach; J Zähringer
Journal:  J Hypertens Suppl       Date:  1986-06
View more
  2 in total

1.  Atrial natriuretic peptide in liver cirrhosis with mild ascites.

Authors:  S Miyase; S Fujiyama; H Chikazawa; T Sato
Journal:  Gastroenterol Jpn       Date:  1990-06

Review 2.  Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?

Authors:  Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.